BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24331847)

  • 21. Spectroscopy imaging in intraoperative MR suite: tissue characterization and optimization of tumor resection.
    Roder C; Skardelly M; Ramina KF; Beschorner R; Honneger J; Nägele T; Tatagiba MS; Ernemann U; Bisdas S
    Int J Comput Assist Radiol Surg; 2014 Jul; 9(4):551-9. PubMed ID: 24142628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic approach for tumor delineation in glioma surgery: 3D MR spectroscopy image-guided resection.
    Zhang J; Zhuang DX; Yao CJ; Lin CP; Wang TL; Qin ZY; Wu JS
    J Neurosurg; 2016 Jun; 124(6):1585-93. PubMed ID: 26636387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of choline compounds with in vitro 1H magnetic resonance spectroscopy for the discrimination of primary brain tumors.
    Sabatier J; Gilard V; Malet-Martino M; Ranjeva JP; Terral C; Breil S; Delisle MB; Manelfe C; Tremoulet M; Berry I
    Invest Radiol; 1999 Mar; 34(3):230-5. PubMed ID: 10084669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease.
    Seeger A; Braun C; Skardelly M; Paulsen F; Schittenhelm J; Ernemann U; Bisdas S
    Acad Radiol; 2013 Dec; 20(12):1557-65. PubMed ID: 24200483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy.
    Kinoshita Y; Yokota A
    NMR Biomed; 1997 Jan; 10(1):2-12. PubMed ID: 9251109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glioma residual or recurrence versus radiation necrosis: accuracy of pentavalent technetium-99m-dimercaptosuccinic acid [Tc-99m (V) DMSA] brain SPECT compared to proton magnetic resonance spectroscopy (1H-MRS): initial results.
    Amin A; Moustafa H; Ahmed E; El-Toukhy M
    J Neurooncol; 2012 Feb; 106(3):579-87. PubMed ID: 21912937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proton and phosphorous MR spectroscopy in squamous cell carcinomas of the head and neck.
    Chawla S; Kim S; Loevner LA; Quon H; Wang S; Mutale F; Weinstein G; Delikatny EJ; Poptani H
    Acad Radiol; 2009 Nov; 16(11):1366-72. PubMed ID: 19608433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience.
    Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK
    J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The contribution of magnetic resonance spectroscopy and echoplanar perfusion-weighted MRI in the initial assessment of brain tumours.
    Fayed N; Modrego PJ
    J Neurooncol; 2005 May; 72(3):261-5. PubMed ID: 15937650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Value of proton magnetic resonance spectroscopy with two-dimensional chemical-shift imaging in evaluating brain gliomas].
    Zhou GF; Wang XY; Gong CG; Liu F; Wang RW
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1342-4. PubMed ID: 18753055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discrepant longitudinal volumetric and metabolic evolution of diffuse intrinsic Pontine gliomas during treatment: implications for current response assessment strategies.
    Löbel U; Hwang S; Edwards A; Li Y; Li X; Broniscer A; Patay Z
    Neuroradiology; 2016 Oct; 58(10):1027-1034. PubMed ID: 27438806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased choline levels coincide with enhanced proliferative activity of human neuroepithelial brain tumors.
    Herminghaus S; Pilatus U; Möller-Hartmann W; Raab P; Lanfermann H; Schlote W; Zanella FE
    NMR Biomed; 2002 Oct; 15(6):385-92. PubMed ID: 12357552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proton observed phosphorus editing (POPE) for in vivo detection of phospholipid metabolites.
    Wijnen JP; Klomp DW; Nabuurs CI; de Graaf RA; van Kalleveen IM; van der Kemp WJ; Luijten PR; Kruit MC; Webb A; Kan HE; Boer VO
    NMR Biomed; 2016 Sep; 29(9):1222-30. PubMed ID: 26601921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amide Proton Transfer Imaging Allows Detection of Glioma Grades and Tumor Proliferation: Comparison with Ki-67 Expression and Proton MR Spectroscopy Imaging.
    Su C; Liu C; Zhao L; Jiang J; Zhang J; Li S; Zhu W; Wang J
    AJNR Am J Neuroradiol; 2017 Sep; 38(9):1702-1709. PubMed ID: 28729292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.
    Law M; Yang S; Wang H; Babb JS; Johnson G; Cha S; Knopp EA; Zagzag D
    AJNR Am J Neuroradiol; 2003; 24(10):1989-98. PubMed ID: 14625221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specificity of choline metabolites for in vivo diagnosis of breast cancer using 1H MRS at 1.5 T.
    Stanwell P; Gluch L; Clark D; Tomanek B; Baker L; Giuffrè B; Lean C; Malycha P; Mountford C
    Eur Radiol; 2005 May; 15(5):1037-43. PubMed ID: 15351906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiparametric MRI With Dynamic Contrast Enhancement, Diffusion-Weighted Imaging, and 31-Phosphorus Spectroscopy at 7 T for Characterization of Breast Cancer.
    Schmitz AM; Veldhuis WB; Menke-Pluijmers MB; van der Kemp WJ; van der Velden TA; Kock MC; Westenend PJ; Klomp DW; Gilhuijs KG
    Invest Radiol; 2015 Nov; 50(11):766-71. PubMed ID: 26135017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mapping extracellular pH in rat brain gliomas in vivo by 1H magnetic resonance spectroscopic imaging: comparison with maps of metabolites.
    García-Martín ML; Hérigault G; Rémy C; Farion R; Ballesteros P; Coles JA; Cerdán S; Ziegler A
    Cancer Res; 2001 Sep; 61(17):6524-31. PubMed ID: 11522650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury.
    Zeng QS; Li CF; Zhang K; Liu H; Kang XS; Zhen JH
    J Neurooncol; 2007 Aug; 84(1):63-9. PubMed ID: 17619225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI.
    Yang D; Korogi Y; Sugahara T; Kitajima M; Shigematsu Y; Liang L; Ushio Y; Takahashi M
    Neuroradiology; 2002 Aug; 44(8):656-66. PubMed ID: 12185543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.